The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses

被引:0
|
作者
Hongming Ma
Lucas J. Adams
Saravanan Raju
Alan Sariol
Natasha M. Kafai
Hana Janova
William B. Klimstra
Daved H. Fremont
Michael S. Diamond
机构
[1] Washington University School of Medicine,Department of Medicine
[2] Washington University School of Medicine,Department of Pathology & Immunology
[3] The University of Pittsburgh,The Center for Vaccine Research and Department of Immunology
[4] Washington University School of Medicine,Department of Biochemistry & Molecular Biophysics
[5] Washington University School of Medicine,Department of Molecular Microbiology
[6] Washington University School of Medicine,Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs
[7] Washington University School of Medicine,Center for Vaccines and Immunity to Microbial Pathogens
来源
Nature Communications | / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Members of the low-density lipoprotein receptor (LDLR) family, including LDLRAD3, VLDLR, and ApoER2, were recently described as entry factors for different alphaviruses. However, based on studies with gene edited cells and knockout mice, blockade or abrogation of these receptors does not fully inhibit alphavirus infection, indicating the existence of additional uncharacterized entry factors. Here, we perform a CRISPR-Cas9 genome-wide loss-of-function screen in mouse neuronal cells with a chimeric alphavirus expressing the Eastern equine encephalitis virus (EEEV) structural proteins and identify LDLR as a candidate receptor. Expression of LDLR on the surface of neuronal or non-neuronal cells facilitates binding and infection of EEEV, Western equine encephalitis virus, and Semliki Forest virus. Domain mapping and binding studies reveal a low-affinity interaction with LA domain 3 (LA3) that can be enhanced by concatenation of LA3 repeats. Soluble decoy proteins with multiple LA3 repeats inhibit EEEV infection in cell culture and in mice. Our results establish LDLR as a low-affinity receptor for multiple alphaviruses and highlight a possible path for developing inhibitors that could mitigate infection and disease.
引用
收藏
相关论文
共 50 条
  • [21] IMMUNOLOGICAL STUDIES ON THE LOW-DENSITY LIPOPROTEIN RECEPTOR
    BEISIEGEL, U
    SCHNEIDER, WJ
    BROWN, MS
    GOLDSTEIN, JL
    FEDERATION PROCEEDINGS, 1981, 40 (06) : 1821 - 1821
  • [22] Oxidized Low-Density Lipoprotein Promotes In Vitro Calcification
    Yamashita, Mamiko
    Nomura, Yoshiaki
    Ishikawa, Misao
    Shimoda, Shinji
    Hanada, Nobuhiro
    MATERIALS, 2020, 13 (22) : 1 - 12
  • [23] Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
    B J W Hennig
    S Hellier
    A J Frodsham
    L Zhang
    P Klenerman
    S Knapp
    M Wright
    H C Thomas
    M Thursz
    A V S Hill
    Genes & Immunity, 2002, 3 : 359 - 367
  • [24] Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
    Hennig, B. J. W.
    Hellier, S.
    Frodsham, A. J.
    Zhang, L.
    Klenerman, P.
    Knapp, S.
    Wright, M.
    Thomas, H. C.
    Thursz, M.
    Hill, A. V. S.
    GENES AND IMMUNITY, 2007, 8 (08) : 707 - 707
  • [25] ATHEROSCLEROSIS - LOW-DENSITY LIPOPROTEIN RECEPTOR HYPOTHESIS
    GOLDSTEIN, JL
    BROWN, MS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (11): : 1257 - 1275
  • [26] Low-density lipoprotein receptor structure and folding
    Gent, J
    Braakman, I
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (19-20) : 2461 - 2470
  • [27] Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
    Hennig, BJW
    Hellier, S
    Frodsham, AJ
    Zhang, L
    Klenerman, P
    Knapp, S
    Wright, M
    Thomas, HC
    Thursz, M
    Hill, AVS
    GENES AND IMMUNITY, 2002, 3 (06) : 359 - 367
  • [28] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [29] The Role of Calcium in Lipoprotein Release by the Low-Density Lipoprotein Receptor
    Zhao, Zhenze
    Michaely, Peter
    BIOCHEMISTRY, 2009, 48 (30) : 7313 - 7324
  • [30] The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Kiouptsi, Klytaimnistra
    Jaeckel, Sven
    Pontarollo, Giulia
    Grill, Alexandra
    Kuijpers, Marijke J. E.
    Wilms, Eivor
    Weber, Christian
    Sommer, Felix
    Nagy, Magdolna
    Neideck, Carlos
    Jansen, Yvonne
    Ascher, Stefanie
    Formes, Henning
    Karwot, Cornelia
    Bayer, Franziska
    Kollar, Bettina
    Subramaniam, Saravanan
    Molitor, Michael
    Wenzel, Philip
    Rosenstiel, Philip
    Todorov, Hristo
    Gerber, Susanne
    Walter, Ulrich
    Jurk, Kerstin
    Heemskerk, Johan W. M.
    van der Vorst, Emiel P. C.
    Doering, Yvonne
    Reinhardt, Christoph
    MBIO, 2019, 10 (05):